ACUTE GVHD IS DISTINGUISHED BY AN ERYTHROID SIGNATURE

被引：0

作者：

Bar, Merav ^{[1
]}

Rinchai, Darawan ^{[2
]}

El Anbari, Mohammed ^{[2
]}

Toufiq, Mohammed ^{[2
]}

Kizhakayil, Dhanya ^{[2
]}

Manjunath, Harshitha S. ^{[2
]}

Mathew, Rebecca ^{[2
]}

Cavattoni, Irene ^{[3
]}

Forer, Sabine ^{[3
]}

Bibawi, Hani ^{[2
]}

Ali, Aesha I. ^{[2
]}

Alater, Ahmad ^{[2
]}

Brown, Clarisa ^{[1
]}

Miles, Nancy ^{[1
]}

Ratsamee, Nellie ^{[1
]}

Phuong Vo ^{[1
]}

Bedognetti, Davide ^{[2
]}

Tomei, Sara ^{[2
]}

Saleh, Ayman ^{[2
]}

Cugno, Chiara ^{[2
]}

Chaussabel, Damien ^{[2
]}

Deola, Sara ^{[2
]}

机构：

[1] Fred Hutchinson Canc Ctr, Seattle, WA USA

[2] Sidra Med, Doha, Qatar

[3] Bolzano Gen Hosp, Bolzano, Italy

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P265

引用

页码：333 / 334

页数：2

共 50 条

[21] Risk factor of acute GvHD
Reza, MM
Paravar, M
Natanzi, HG
Alimoghaddam, K
Ghavamzadeh, A
BONE MARROW TRANSPLANTATION, 2005, 35 : S339 - S339
[22] A Hybrid Threshold Group Signature Scheme with Distinguished Signing Authority
Dao Tuan Hung
Nguyen Hieu Minh
Nguyen Nam Hai
INFORMATION SYSTEMS DESIGN AND INTELLIGENT APPLICATIONS, INDIA 2017, 2018, 672 : 64 - 72
[23] Equine acute erythroid leukemia
Panziera, Welden
Tessele, Bianca
Bianchi, Ronaldo
Tochetto, Camila
De la Corte, Flavio
Brass, Karin
Fighera, Rafael
CIENCIA RURAL, 2015, 45 (12): : 2214 - 2217
[24] Transplant-associated renal microangiopathy is associated with a high risk of refractory acute GVHD and characterized by a specific biomarker signature
Zeisbrich, M.
Beimler, J.
Zeier, M.
Falk, C. S.
Ho, A. D.
Dreger, P.
Luft, T.
BONE MARROW TRANSPLANTATION, 2015, 50 : S22 - S23
[25] Minnesota acute GvHD risk score defines survival at onset of acute GvHD after PTCY prophylaxis
Ardizzoia, F.
Lorentino, F.
Bruno, A.
Greco, R.
Marktel, S.
Giglio, F.
Clerici, D.
Farina, F.
Mastaglio, S.
Piemontese, S.
Assanelli, A. A.
Carrabba, M. G.
Bernardi, M.
Corti, C.
Peccatori, J.
Ciceri, F.
Lupo-Stanghellini, M. T.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 40 - 41
[26] An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome
Ebert, Benjamin L.
Galili, Naomi
Tamayo, Pablo
Bosco, Jocelyn
Mak, Raymond
Pretz, Jennifer
Tanguturi, Shyam
Ladd-Acosta, Christine
Stone, Richard
Golub, Todd R.
Raza, Azra
PLOS MEDICINE, 2008, 5 (02) : 312 - 322
[27] Determining prognosis for patients with acute GVHD in real time: Development and testing of an acute GVHD activity index
McDonald, GB
Leisenring, WM
Martin, PJ
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 13 - 13
[28] A More MAGICal Alogrithm in Acute GVHD
Hong, Sanghee
Sarantopoulos, Stefanie
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 347 - 348
[29] Clinical applications of acute GVHD biomarkers
Levine, J. E.
ONKOLOGIE, 2012, 35 : 28 - 28
[30] The utility of biomarkers in acute GVHD prognostication
Spyrou, Nikolaos
Akahoshi, Yu
Ayuk, Francis
Holler, Ernst
Choe, Hannah
Etra, Aaron
Hogan, William J.
Roesler, Wolf
Hexner, Elizabeth
DeFilipp, Zachariah
Reshef, Ran
Chanswangphuwana, Chantiya
Qayed, Muna
Kraus, Sabrina
Eder, Matthias
Javorniczky, Nora Rebeka
Grupp, Stephan A.
Kitko, Carrie L.
Merli, Pietro
Aguayo-Hiraldo, Paibel
Woelfl, Matthias
Baez, Janna
Beheshti, Rahnuma
Eng, Gilbert
Gleich, Sigrun
Katsivelos, Nikolaos
Khan, Alina
Kowalyk, Steven
Morales, George
Young, Rachel
Nakamura, Ryotaro
Chen, Yi-Bin
Levine, John E.
Ferrara, James L. M.
BLOOD ADVANCES, 2023, 7 (17) : 5152 - 5155

← 1 2 3 4 5 →